| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
10,614 |
8,898 |
$509K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,227 |
6,390 |
$242K |
| 87428 |
|
919 |
841 |
$49K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,051 |
907 |
$16K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
235 |
205 |
$14K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
83 |
82 |
$5K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
77 |
71 |
$3K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
42 |
41 |
$3K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
29 |
29 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
160 |
146 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
84 |
41 |
$983.96 |
| 87807 |
|
49 |
46 |
$541.63 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
32 |
28 |
$472.35 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
23 |
18 |
$433.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
175 |
161 |
$237.50 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
18 |
13 |
$90.47 |
| 81003 |
|
33 |
25 |
$52.75 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
13 |
12 |
$23.22 |
| G0008 |
Administration of influenza virus vaccine |
12 |
12 |
$0.00 |